| Study year |
Follow-up |
Adverse events |
Clinical outcome |
Imaging outcome |
| |
Months |
Major |
Improvement |
Stable |
Worsened |
Improvement |
Stable |
Worsened |
| Bonab, 2012 |
12 |
None |
4/22 |
12/22 |
6/22 |
0/22 |
15/22 |
6/22 |
| Connick, 2012 |
10 |
None |
10/10 |
0/10 |
0/10 |
Not significant |
| Odianc, 2011 |
12 |
None |
6/8 |
1/8 |
1/8 |
|
|
|
| Karussis, 2010 |
6 |
Transient aseptic
meningitis |
15/15 |
0/15 |
0/15 |
15/15 |
0/15 |
0/15 |
| Yamout, 2010 |
12 |
Transient encephalopathy
and seizure |
5/7 |
1/7 |
1/7 |
0/7 |
2//7 |
5/7 |
| Bonab, 2007 |
19 |
None |
1/10 |
4/10 |
5/10 |
1/10 |
7/10 |
2/10 |
| Riordan, 2009 |
12 |
None |
3/3 |
0/3 |
0/3 |
0/3 |
3/3 |
0/3 |
| Rice, 2011 |
12 |
None |
6/6 |
0/6 |
0/6 |
6/6 |
0/6 |
0/6 |
| Liang, 2009 |
12 |
None |
1/1 |
0/1 |
0/1 |
1/1 |
0/1 |
0/1 |
| Total: |
6-19 |
|
51/82
(62%) |
18/82
(22%) |
13/82
(16%) |
23/64
(36%) |
27/64
(42%) |
13/64
(20%) |
|
